Scientists test double immunotherapy with radiation for tough lung cancers

This early-stage study tested the safety of combining two immunotherapy drugs (atezolizumab and varlilumab) with targeted radiation in patients with advanced non-small cell lung cancer that had spread and stopped responding to standard treatments. The goal was to see if this three-part approach could help control the cancer for longer by boosting the immune system's attack while using radiation to shrink tumors. The trial was small and focused primarily on identifying side effects and determining safe dosage levels.